✨
AI Summary
- Shannon Boye details Atsena Therapeutics' gene therapy strategy for Stargardt disease.
- Focus on differentiated delivery, dual-vector design, and a go/no-go framework.
- Leveraging clinical experience to advance gene therapy for rare inherited diseases.
Guests on This Episode
SP
Shannon Boye, Ph.D
1 podcast appearance